The text discusses various studies related to colon cancer, including the use of fluorouracil and leucovorin as adjuvant therapy, the identification and management of hereditary predisposition to colorectal cancer, the role of T cells in predicting outcomes, the Immunoscore classification, the impact of PIK3CA mutation and aspirin use on survival, and the screening for dihydropyrimidine dehydrogenase deficiency.